Distinct cAMP signaling pathways differentially regulate α2C-adrenoceptor expression: role in serum induction in human arteriolar smooth muscle cells
Open Access
- 1 January 2005
- journal article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 288 (1) , H69-H76
- https://doi.org/10.1152/ajpheart.01223.2003
Abstract
The physiological role of α2-adrenoceptors (α2-ARs) in cutaneous, arteriolar, vascular smooth muscle cells (VSMs) is to mediate cold-induced constriction. In VSMs cultured from human cutaneous arterioles, there is a selective increase in α2C-AR expression after serum stimulation. In the present study, we examined the cellular mechanisms contributing to this response. Serum induction of α2C-ARs was paralleled by increased expression of cyclooxygenase-2 (COX-2), increased release of prostaglandins, and increased intracellular concentration of cAMP. Inhibition of COX-2 by acetyl salicylic acid (1 mM), NS-398 (5 μM), or celecoxib (3 μM) abolished the increase in cAMP and markedly reduced α2C-AR induction in response to serum stimulation. The cAMP agonists, forskolin (10 μM), isoproterenol (10 μM), and cholera toxin (0.1 μg/ml) each dramatically increased expression of α2C-ARs in human cutaneous VSMs. The A-kinase inhibitor H-89 (2 μM) inhibited phosphorylation of cAMP response element binding protein, but not the increase in α2C-AR expression in response to these agonists. cAMP-dependent but A-kinase independent signaling can involve activation of guanine nucleotide exchange factors for the GTP-binding protein, Rap. Indeed, pull-down assays demonstrated Rap1 activation by serum and forskolin in VSM. Transient transfections using α2C-AR promoter-luciferase reporter construct demonstrated that Rap1 increased reporter activity, whereas the A-kinase catalytic subunit decreased reporter activity. These results indicate that cAMP signaling can have dual effects in cutaneous VSMs:activation of α2C-AR transcription mediated by Rap1 GTPase and suppression mediated by A-kinase. The former effect predominates in serum-stimulated VSMs leading to a COX-2, cAMP, and Rap 1-dependent increase in α2C-AR expression. Such increased expression of α2C-ARs may contribute to enhanced cold-induced vasoconstriction and Raynaud's phenomenon.Keywords
This publication has 28 references indexed in Scilit:
- Regulation of α2-adrenoceptors in human vascular smooth muscle cellsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- MAP Kinase Kinase 6–p38 MAP Kinase Signaling Cascade Regulates Cyclooxygenase-2 Expression in Cardiac Myocytes In Vitro and In VivoCirculation Research, 2003
- Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2Science, 2002
- Raynaud's phenomenonThe Lancet, 2001
- Rap1 signalling: adhering to new modelsNature Reviews Molecular Cell Biology, 2001
- Prostanoid Receptors: Subtypes and SignalingAnnual Review of Pharmacology and Toxicology, 2001
- Mechanism of Regulation of the Epac Family of cAMP-dependent RapGEFsJournal of Biological Chemistry, 2000
- Silent α2C-adrenergic receptors enable cold-induced vasoconstriction in cutaneous arteriesAmerican Journal of Physiology-Heart and Circulatory Physiology, 2000
- p38 Mitogen-activated Protein Kinase Regulates Cyclooxygenase-2 mRNA Stability and Transcription in Lipopolysaccharide-treated Human MonocytesJournal of Biological Chemistry, 1999
- Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMPNature, 1998